enVVeno Medical Corp (NVNO) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -16.75M USD | Operating Income (Loss) |
| Revenue | (m) | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 8.72M USD | Research and Development Expense |
| Selling, general and administration | 8.03M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-16.75M | (m) | (m) | $8.72M | $8.03M | (m) |
| 2026-03-31 | $-20.01M | (m) | (m) | $9.54M | $10.47M | (m) |
| 2025-12-31 | $-20.90M | (m) | (m) | $9.98M | $10.92M | (m) |
| 2025-09-30 | $-23.59M | (m) | (m) | $11.55M | $12.04M | (m) |
| 2025-06-30 | $-24.87M | (m) | (m) | $11.82M | $13.05M | (m) |
| 2025-03-31 | $-23.28M | (m) | (m) | $11.75M | $11.52M | (m) |
| 2024-12-31 | $-23.83M | (m) | (m) | $12.25M | $11.58M | (m) |
| 2024-09-30 | $-23.41M | (m) | (m) | $11.72M | $11.69M | (m) |
| 2024-06-30 | $-22.58M | (m) | (m) | $11.65M | $10.93M | (m) |
| 2024-03-31 | $-23.94M | (m) | (m) | $13.04M | $10.90M | (m) |
| 2023-12-31 | $-25.24M | (m) | (m) | $13.58M | $11.65M | (m) |
| 2023-09-30 | $-25.42M | (m) | (m) | $13.40M | $12.02M | (m) |
| 2023-06-30 | $-26.22M | (m) | (m) | $13.10M | $13.13M | (m) |
| 2023-03-31 | $-26.39M | (m) | (m) | $11.96M | $14.44M | (m) |
| 2022-12-31 | $-24.93M | (m) | (m) | $9.91M | $15.02M | (m) |
| 2022-09-30 | $-27.46M | (m) | (m) | $8.90M | $18.57M | (m) |
| 2022-06-30 | $-24.02M | (m) | (m) | $7.63M | $16.39M | (m) |
| 2022-03-31 | $-19.42M | (m) | (m) | $5.65M | $13.77M | (m) |
| 2021-12-31 | $-16.89M | (m) | (m) | $5.73M | $11.16M | (m) |
| 2021-09-30 | $-12.06M | (m) | (m) | $6.22M | $5.84M | (m) |
| 2021-06-30 | $-11.27M | (m) | (m) | $5.76M | $5.52M | (m) |
| 2021-03-31 | $-10.43M | (m) | (m) | $5.37M | $5.06M | (m) |
| 2020-12-31 | $-9.14M | (m) | (m) | $4.25M | $4.88M | (m) |
| 2020-09-30 | $-7.28M | (m) | (m) | $2.76M | $3.92M | (m) |
| 2020-06-30 | $-7.19M | (m) | (m) | $2.68M | $3.92M | (m) |
| 2020-03-31 | $-7.60M | (m) | (m) | $2.40M | $4.61M | (m) |
| 2019-12-31 | $-7.68M | $31.24K | (m) | $2.21M | $4.91M | -24566.50% |
| 2019-09-30 | $-7.18M | $61.70K | (m) | $1.71M | $5.21M | -11628.31% |
| 2019-06-30 | $-6.83M | $103.37K | (m) | $1.46M | $5.15M | -6606.42% |
| 2019-03-31 | $-7.98M | $186.73K | (m) | $1.31M | $6.54M | -4273.92% |
| 2018-12-31 | $-7.85M | $186.55K | (m) | $1.24M | $6.48M | -4210.51% |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $-6.10M | $422.11K | (m) | $649.74K | $5.46M | -1445.89% |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |